Awareness of physicians and pharmacists of aldosterone antagonists in heart failure and myocardial infarction in Jordan.

there is an under-use of aldosterone antagonists in HF and post-MI patients, and a lack of detailed awareness of current guidelines among health care providers. Dissemination of evidence-based guidelines and usage protocols may improve management of post-MI and HF.